Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Virginie Siguret

Professor

Université Paris Descartes

France

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacology

40%

Pharmacotherapy

20%

Thrombosis

40%

Hemostasis

40%

Pharmacometrics

20%

Bleeding Disorders

20%

Therapeutic Drug Monitoring

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles16

Results of an international survey on the management of therapeutic intensity unfractionated heparin: communication from the SSCs of the ISTH

Article Link

Year:

2025

Evaluation of the Inverted Classroom Approach in a Case-Study Course on Antithrombotic Drug Use in a PharmD Curriculum: French Monocentric Randomized Study

Article Link

Year:

2025

Cerebral Venous Thrombosis and Nitrous Oxide Intoxication: Report of Two Cases and Review of the Literature

Article Link

Year:

2025

Effect of Selective Serotonin Reuptake Inhibitors on Coagulation: Fact or Fiction?

Article Link

Year:

2025

Moyamoya Angiopathy and Antiphospholipid Antibodies: A Coincidental Association?

Article Link

Year:

2025

Management of Therapeutic-intensity Unfractionated Heparin: A Narrative Review on Critical Points

Article Link

Year:

2024

Comparisons between diluted thrombin time, ecarin chromogenic assays, and UPLC–MS for plasma level dabigatran quantification: Results from DRIVING study

Article Link

Year:

2023

Practical Nomogram Predicting Apixaban or Rivaroxaban Concentrations from Low-Molecular-Weight Heparin Anti-Xa Values: Special Interest in Acute Ischemic Stroke Patients

Article Link

Year:

2023

Assessment of DOAC in GEriatrics (ADAGE study): rivaroxaban/apixaban concentrations and thrombin generation profiles in NVAF very elderly patients

Article Link

Year:

2022

Relapse of acquired von Willebrand syndrome in a patient non-compliant with Crohn's disease

Article Link

Year:

2022

GFHT proposals on the practical use of argatroban — With specifics regarding vaccine-induced immune thrombotic thrombocytopaenia (VITT)

Article Link

Year:

2021

Is platelet function testing at the acute phase under P2Y12 inhibitors helpful in predicting bleeding in real-life patients with acute coronary syndrome? The AVALANCHE study

Article Link

Year:

2021

Bleeding and Thrombosis: Insights into Pathophysiology of <i>Bothrops</i> Venom-Related Hemostasis Disorders

Article Link

Year:

2021

Induced forms of α2-macroglobulin neutralize heparin and direct oral anticoagulant effects

Article Link

Year:

2021

Prevention of venous thromboembolism and haemostasis monitoring in patients with COVID-19: Updated proposals (April 2021)

Article Link

Year:

2021

Study of thrombin generation with St Genesia to evaluate xaban pharmacodynamics: Analytical performances over 18 months

Article Link

Year:

2021

Collaborators8

Alexandre Mansour

FRANCE

Carmelo Lafuente-Lafuente

Sorbonne Université

FRANCE

Jean-Philippe Chippaux

Université Paris Cité

FRANCE

Georges JOURDI

Clinical Pathologist & Ass. Prof. (MCU-PH)

Assistance Publique - Hôpitaux de Paris

FRANCE

Jerrold Levy

Professor and CoDirector Cardiothoracic ICU

Duke University School of Medicine

UNITED STATES

Thomas Pierre Lecompte

full professor

Université de Lorraine

FRANCE

Chloe James

Professor

University of Bordeaux

FRANCE

Pierre SIE

Pr, Head of laboratory

Université Toulouse III - Paul Sabatier

FRANCE

How do I reach out?

Meet Kite AI